Bacterial News and Research

RSS

Researchers delve deeper into the structure of protein receptor crucial for cardiovascular health

5 Aug 2022

New method can modify an entire substance class of medically relevant natural products

The use of the element fluorine to modify active substances is an important tool in modern drug development.

5 Aug 2022

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

A new study investigated how the gut microbiome confers immunity to mammalian hosts against SARS-CoV-2 intranasal infection by generating short-chain fatty acids.

5 Aug 2022

KAIST researchers engineer a bacterial strain capable of producing lutein

A research group at KAIST has engineered a bacterial strain capable of producing lutein. The research team applied systems metabolic engineering strategies, including substrate channeling and electron channeling, to enhance the production of lutein in an engineered Escherichia coli strain.

4 Aug 2022

Early-life acquisition of antibiotic resistance in neonates from developing countries

Every year, almost 7 million potentially serious bacterial infections are estimated to occur in newborns, resulting in more than 550,000 annual neonatal deaths.

4 Aug 2022

Mitochondrial DNA mutations are associated with an increased risk of atherosclerosis

Mitochondria are organelles found within most cells, best known for generating the chemical energy required to power cellular functions.

4 Aug 2022

Using native microbes as chassis for transgene delivery in live bacterial therapeutics

Residing within the human gut are trillions of bacteria and other microorganisms that can impact a variety of chronic human ailments, including obesity, type 2 diabetes, atherosclerosis, cancer, non-alcoholic fatty liver disease and inflammatory bowel disease.

4 Aug 2022

New low-calorie sweetener could potentially have a prebiotic effect on the gut microbiome

From the wide variety of sodas, candies and baked goods that are sold worldwide, it's clear that people love their sweet treats.

4 Aug 2022

Polymer-embedded copper-based nanoparticles prevent surface contamination by viruses

In a new study, researchers developed nanocomposite coatings to prevent surface contamination by a human coronavirus (HCoV).

4 Aug 2022

Researchers unravel mechanism of action of bacterial Tc toxin in fatal attacks

A harmful and often deadly substance made by bacteria, a bacterial toxin manipulates host cell functions and disrupts vital cell processes in a living organism.

3 Aug 2022

Fruit fly genome contains whole genomes of a kind of bacteria, study finds

A fruit fly genome is not a just made up of fruit fly DNA – at least for one fruit fly species. New research from the University of Maryland School of Medicine's (UMSOM) Institute for Genome Sciences (IGS) shows that one fruit fly species contains whole genomes of a kind of bacteria, making this finding the largest bacteria-to-animal transfer of genetic material ever discovered. The new research also sheds light on how this happens.

3 Aug 2022

High prevalence of fungal secondary infections among COVID-19 patients

Researchers analyze literature to explore the frequency of secondary fungal infections among COVID-19 patients.

2 Aug 2022

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Lyme disease has experienced notable growth in the United States over the past 15 years and, as a result, has become an illness of increasing national concern. From 2007 to 2021, private insurance claim lines with Lyme disease diagnoses rose 357 percent in rural areas and 65 percent in urban areas. These and other findings on this tick-borne, bacterial illness were captured in an infographic just released by FAIR Health. The national, independent organization used its database of over 36 billion privately billed healthcare claims to conduct its 15-year analysis of Lyme disease; this analysis builds upon a previous FAIR Health infographic that studied 10 years of Lyme disease data.

2 Aug 2022

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

2 Aug 2022

Symptoms of monkeypox differ from previous outbreaks

A new study describes the clinical characteristics of monkeypox infections during the current outbreak.

1 Aug 2022

Study quantifies link between red meat intake, gut microbiome, and cardiovascular disease in older adults

Does eating more meat - especially red meat and processed meat - raise the risk of cardiovascular disease, and if so, why? Despite intense study, the impact of animal source foods on atherosclerotic cardiovascular disease (ASCVD) is vigorously debated, and the mechanisms underlying potential effects of animal proteins remain unclear.

1 Aug 2022

Is cannabidiol effective against COVID-19?

A new study discusses the utility of CBD in treating the inflammatory symptoms of COVID-19

31 Jul 2022

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

Wake Forest Institute for Regenerative Medicine researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy – immune checkpoint blockage, a promising cancer treatment development – to determine why some patients don't respond or develop a resistance to the treatment over time.

29 Jul 2022

Researchers investigate the protection against meningococcal infection in hematopoietic stem cell transplant recipients

The team in the Hematology Department at Henri Mondor AP-HP Hospital, coordinated by Dr. Christine Robin, and scientists from the Institut Pasteur (the Invasive Bacterial Infections Unit led by Professor Muhamed-Kheir Taha) recently studied protection against meningococcal infection in patients who had received hematopoietic stem cell transplantation.

29 Jul 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Bacterial News and Research

Researchers delve deeper into the structure of protein receptor crucial for cardiovascular health

New method can modify an entire substance class of medically relevant natural products

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

KAIST researchers engineer a bacterial strain capable of producing lutein

Early-life acquisition of antibiotic resistance in neonates from developing countries

Mitochondrial DNA mutations are associated with an increased risk of atherosclerosis

Using native microbes as chassis for transgene delivery in live bacterial therapeutics

New low-calorie sweetener could potentially have a prebiotic effect on the gut microbiome

Polymer-embedded copper-based nanoparticles prevent surface contamination by viruses

Researchers unravel mechanism of action of bacterial Tc toxin in fatal attacks

Fruit fly genome contains whole genomes of a kind of bacteria, study finds

High prevalence of fungal secondary infections among COVID-19 patients

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Symptoms of monkeypox differ from previous outbreaks

Study quantifies link between red meat intake, gut microbiome, and cardiovascular disease in older adults

Is cannabidiol effective against COVID-19?

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

Researchers investigate the protection against meningococcal infection in hematopoietic stem cell transplant recipients

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News